Accéder au contenu
Merck

Fish oil omega-3 fatty acids reduce the severity of radiation-induced oxidative stress in the rat brain.

International journal of radiation biology (2014-06-18)
Helen N Saada, Ussama Z Said, Elsayed M E Mahdy, Hattem E Elmezayen, Shereen M Shedid
RÉSUMÉ

To evaluate the modulator role of fish oil (FO) on some biochemical changes in the brain of gamma-irradiated rats (RAD). Male albino rats Sprague Dawley were divided into four groups (n = 10). (i) received vehicle via gavages during 28 days; (ii) FO: received fish oil (400 mg/kg/day) via gavages during 28 days; (iii) RAD: received vehicle for 7 days before whole body gamma-irradiation with 8 Gy given in four fractions each 7 days apart and continued during the irradiation period; and (iv) FO+ RAD: received FO for 7 days before exposure to the first dose of irradiation and FO treatment was continued during the irradiation period. Animals were sacrificed 24 hours post the last irradiation dose. A significant increase of malondialdehyde (MDA) and protein carbonyl (CO) content associated with a significant decrease of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) activities and glutathione (GSH) content were recorded in the brain of irradiated rats. Oxidative stress was accompanied by a significant decrease of eicosapentaenoic (EPA) and docosahexaenoic (DHA) levels. Aspartic (Asp) and glutamic (Glu) acid levels were increased. Serotonin level showed a decrease associated with enhanced monoamine oxidase (MAO) activity and increased 5-hydroxyindolacetic acid (5-HIAA) level. FO treatment reduced the severity of radiation-induced oxidative stress, alteration of Asp and Glu levels and serotonin metabolism concomitant with increased EPA and DHA levels. FO attenuates the severity of radiation-induced biochemical disorders in the brain by counteracting the radiation-induced decrease of EPA and DHA. Further studies are needed concerning the long-term implications of our findings.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
L-Glutamic acid, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Acide L-aspartique, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
Acide cis-4,7,10,13,16,19-docosahexaénoïque, ≥98%
Sigma-Aldrich
L-Glutamic acid, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-100.5%
Sigma-Aldrich
Acide L-aspartique, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Glutamic acid, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
Acide L-aspartique, BioXtra, ≥99% (HPLC)
Sigma-Aldrich
D-Glutamic acid, ≥99% (TLC)
Sigma-Aldrich
L-Aspartic acid potassium salt, ≥98% (HPLC)
Sigma-Aldrich
Acide L-aspartique, BioUltra, ≥99.5% (T)
Sigma-Aldrich
DL-Aspartic acid, ≥99% (TLC)
Sigma-Aldrich
L-Glutamic acid hydrochloride
SAFC
Acide L-aspartique
Sigma-Aldrich
L-Glutamic acid, FCC
Supelco
L-Glutamic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Acide cis-4,7,10,13,16,19-docosahexaénoïque, analytical standard
Supelco
Acide L-aspartique, Pharmaceutical Secondary Standard; Certified Reference Material
Glutamic acid, European Pharmacopoeia (EP) Reference Standard
Acide L-aspartique, European Pharmacopoeia (EP) Reference Standard
Supelco
L-Glutamic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Acide L-aspartique, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland